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Abstract
Background: The syndrome of vital exhaustion (VE), characterized by fatigue and irritability, may contribute to an 
increased risk of atherosclerosis. The aim of the study was to explore sex differences in the interactions of VE with 
endothelial dysfunction and VE with reduced carotid elasticity, the important contributors to the development of early 
atherosclerosis, on preclinical atherosclerosis.
Methods: The participants were 1002 women and 719 men aged 24-39 examined in the Cardiovascular Risk in Young 
Finns study. Vital exhaustion was measured using the Maastricht Questionnaire. Preclinical atherosclerosis was assessed 
by carotid intima-media thickness (IMT), endothelial function was measured by brachial flow-mediated dilatation 
(FMD), and arterial elasticity by carotid artery compliance (CAC) using ultrasound techniques.
Results: We found a significant CAC x VE interaction for IMT only for the men. Our results imply that high VE level 
significantly related to high IMT levels among the men with low CAC, but not among the women with low CAC or 
among the women or men with high CAC. No significant FMD x VE interactions for IMT for the women or men were 
found.
Conclusions: High VE may exert an effect on IMT for men with impaired arterial elasticity. The results suggest that high 
vitally exhausted men with reduced arterial elasticity are at increased risk of atherosclerosis in early life and imply men's 
decreased stress coping in relation to stressful psychological coronary risk factors.
Background
Coronary heart disease (CHD) is the leading cause of
morbidity and mortality in the industrialized world [1].
Atherosclerosis is the pathogenic process that underlies
most cardiovascular diseases, including the pathology of
CHD [2]. According to the prognosis of the World Health
Organization, stressful life events and chronic psychoso-
cial stress will be the most harmful risk factors for the
development of cardiovascular diseases in the near future
[3]. Recent studies have shown that chronic life stress is a
significant risk factor for cardiovascular mortality [4],
and chronic psychosocial stress has been found to con-
tribute on endothelial dysfunction [5], fostering, there-
fore, the progression of atherosclerosis [6].
It is known that endothelial dysfunction is a marker of
cardiovascular [7] and atherosclerotic [8] risk and it trig-
gers the first step of atherosclerosis [9]. The alterations in
the functioning of the vascular endothelium may influ-
ence the associations between the risk factors and athero-
sclerosis progression [10]. Brachial flow-mediated
dilatation (FMD) serves as an adequate non-invasive
measure of endothelial function [11] and carotid arterial
compliance (CAC) as a valid index of arterial elasticity
[12]. CAC may also serve as an additional indicator of
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early atherosclerosis [7,13]. Reduced FMD [14] and
decreased arterial compliance [15] have been shown in
the Cardiovascular Risk in Young Finns (CRYF) study to
be related to the increased intima-media thickness
(IMT), whereas increased IMT correlates with coronary
atherosclerosis [16]. IMT is a marker of preclinical ath-
erosclerosis, and it has been found to predict future car-
diovascular disease independent of traditional risk
factors [17].
Vital exhaustion (VE) has been considered to be a type
of chronic mental stress, and it is characterized by height-
ened irritability, fatigue and demoralizing feelings [18].
Vital exhaustion has been associated with coronary
events [18] and coronary heart disease [19]. A state of VE
has shown to be one of the risk indicators for myocardial
infarction [20] and for stroke [21] and it has been sug-
gested to be predictive for atherothrombotic events
[22,23]. Our recent studies have shown that VE may con-
tribute to an increased risk of early atherosclerosis in
young healthy adults [24,25].
Several years ago, Appels has described a state of VE,
characterized by the symptoms of tiredness, physical
exhaustion and feeling of hopelessness as a prodromal
state in cardiovascular patients [18]. Appels has sug-
gested that symptoms of VE can precede CHD events,
perhaps, through the neuroendocrine mechanisms. Later,
a number of additional linking mechanisms, such as
proinflammatory and procoagulant changes and
increased pathogen burden have been found to partici-
pate in VE symptomatology as well as in cardiovascular
and chronic stress relationships [26-31]. The exploration
of these mechanisms is highly important, because athero-
sclerosis has recently been shown to be a chronic inflam-
matory process [32]. However, neuroendocrine
mechanisms cannot be excluded from the possible rela-
tions between VE and atherogenesis. The HPA axis [33]
and the sympathetic-parasympathetic balance [34] as well
as inflammatory mediators have been suggested to be
involved in the psychological stress-related atherogenesis
[35]. Moreover, atherogenic process has been considered
to be a neurogenic phenomenon resulted from ANS
imbalance towards a state of sympathetic hyperactivity
[36]. In accordance with this hypothesis, the harmful
influence of cardiovascular risk factors in relation to ath-
erosclerosis may be mediated by the interactions between
ANS regulation and endothelial function [37]. Chronic
stress-related neuroendocrine mechanisms can play a
role in the development of endothelial dysfunction [35].
Endothelial dysfunction may, in turn, lead to structural
alterations of the arterial walls [38]. Based on these find-
ings we hypothesized that a high level of VE in combina-
tion with impaired endothelial function or reduced
arterial elasticity may be related to a disproportionately
high development of preclinical atherosclerosis
(increased IMTs).
Data from several studies demonstrate that cardiovas-
cular mortality and the lifetime risk of the CHD develop-
ment is higher in men compared to women, especially in
stressful life conditions [1]. Men from industrialized east-
ern European countries demonstrated more VE and
fewer effective coping strategies than women and men
living in the West [39]. It has been shown that women
develop atherosclerosis later than men probably because
of the estrogen's protective role [40]. In our recent study,
an increased risk of atherosclerosis has been shown in
men compared to women [41]. Based on these findings
we hypothesized that the effect of high VE in combina-
tion with impaired endothelial functioning in relation to
the risk of atherosclerosis is most pronounced in men.
More specifically, we expected that a high level of VE in
combination with impaired endothelial function (low
FMD) or reduced arterial elasticity (low CAC) would be
related to increased risk of atherosclerosis (increased
IMTs) in men. We studied the interaction of VE and
endothelial dysfunction, measured by FMD, on preclini-
cal atherosclerosis, assessed by carotid IMT, in young
healthy men and women aged 24-39 years concentrating
on sex differences. In addition, we investigated the inter-
action of VE and CAC on carotid IMT separately for the
men and women. We also took into account the effects of
cardiovascular risk factors associated with ultrasound
variables in the CRYF study [10,14,15,42]: serum LDL-
cholesterol levels, serum HDL-cholesterol levels, triglyc-
eride levels, systolic and diastolic blood pressure.
Methods
Subjects
The participants are from the sample of the ongoing pro-
spective epidemiological Cardiovascular Risk in Young
Finns study [43] which is investigating the risk factors and
precursors of cardiovascular diseases and their determi-
nants in 3596 healthy children, adolescents and young
adults from different parts of Finland [43]. In the CRYF
sample, carotid IMT, CAC and brachial FMD were mea-
sured in 2001. Complete data on carotid and brachial
artery ultrasound measurements were available for 2109
subjects aged 24 to 39 years. Vital exhaustion was also
measured in 2001; valid VE questionnaires were obtained
from 2080 participants. The final sample of the current
study comprised 1002 women and 719 men.
The study followed the guiding principles of the Hel-
sinki Declaration and was approved by the local ethics
committees. All the subjects gave their written, informed
consent.
Vital exhaustion
Vital exhaustion was assessed with the Maastricht Ques-
tionnaire (MQ), a 21-item checklist of signs and symp-
toms of exhaustion [44]. The MQ has been designed for
self-application. It has been specially developed to assessChumaeva et al. BMC Cardiovascular Disorders 2010, 10:34
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feelings of exhaustion. The MQ consists of 21 questions
asking about symptoms of VE state: increased irritability,
unusual fatigue, loss of energy and feelings of demoraliza-
tion, all scored as absent or present. An analysis of the
items which are included in MQ and indicate VE feelings
has shown the significant associations between the items
and cardiovascular diseases [44]. The questionnaire con-
sisted of the following questions regarding the presence
or absence of feelings of fatigue, irritability and demoral-
ization: "Do you ever wake up with a feeling of exhaustion
and fatigue? Do little things irritate you more lately then
used do? Do you feel you want to give up trying? Do you
la t e ly f ee l m or e  list l es s  t ha n be f or e ?"  [44].  Ea c h of  t he
items was rated on a three-point scale, ranging from 0 to
2. The answer's variables were: "no" = 0, "I cannot say" = 1
and "yes" = 2. The mean score of all the items was used to
index the level of VE. Cronbach's alpha was 0.92, indicat-
ing good reliability. The questionnaire was sent to the
participants to be completed at home.
Ultrasound imaging
Ultrasound studies of the carotid and brachial arteries
were performed using Sequoia 512 ultrasound main-
f r a m e s  ( A c u s o n ,  M o u n t a i n  V i e w ,  C A,  U S A )  w i t h  1 3 . 0
MHz linear array transducer, as previously described
[14]. To assess intra-individual reproducibility of ultra-
sound measurements, 57 subjects were re-examined 3
months after the initial visit (2.5% random sample).
Carotid intima-media thickness, IMT
Carotid IMT was measured on the posterior (far) wall of
the left carotid artery. At least four measurements were
taken approximately 10 mm proximal to the bifurcation
to derive mean carotid IMT. The between-visit coeffi-
cient of variation (CV) of IMT measurements was 6.4%
and the intra-observer CV was 3.4% [10].
Brachial flow-mediated dilatation, FMD
To assess brachial FMD, the left brachial artery diameter
was measured both at rest and during reactive hypere-
mia. Increased flow was induced by inflation of a pneu-
matic tourniquet placed around the forearm to a pressure
of 250 mmHg for 4.5 min, followed by a release [14].
Arterial diameter was measured at end-diastole at a fixed
distance from an anatomic marker at rest and 40, 60 and
80 s after cuff release. The vessel diameter in scans after
reactive hyperemia was expressed as the percentage rela-
tive to the resting scan. The average of three measure-
ments at each time point was used to derive the
maximum FMD (the greatest value between 40 to 80 s).
All ultrasound scans were analyzed by a single reader
blinded to the subject's details [14]. The between-visit
CV for brachial diameter was 3.2% and for FMD 26.0%
[14]. Intra-observer CV was 1.2% for brachial diameter
and 15.3% for FMD [10].
Carotid artery compliance, CAC
Several moving image clips of the beginning of the
carotid bifurcation and the common carotid artery with a
duration of 5 s were recorded and stored in digital format
for subsequent off-line analysis. The best quality cardiac
cycle was selected from the clip images. The carotid
diameter was measured at least twice (spatial measure-
ments) in end-diastole and end-systole, respectively. The
mean of the measurements was used as the end-diastolic
or end-systolic diameter. Blood pressure was measured
during the ultrasound study with an automated sphygmo-
manometer (Omron M4, Omron Matsusaka Co., Ltd,
Japan). Ultrasound and concomitant brachial blood pres-
sure measurements were used to calculate carotid com-
pliance (CAC = [(Ds - Dd)/Dd]/(Ps - Pd), where Dd is
diastolic diameter, Ds is systolic diameter, Ps is systolic
blood pressure, and Pd is diastolic blood pressure). The
between-visit CV was 2.7% for diastolic diameter and
16.3% for CAC [15]. Intra-observer CV was 1.4% for dia-
stolic diameter and 13.6% for CAC [10].
Clinical Characteristics and Cardiovascular Risk Factors
We took into account the effects of serum LDL-choles-
terol levels, serum HDL-cholesterol levels, triglyceride
levels, systolic and diastolic blood pressure. For the deter-
mination of serum lipoprotein levels, venous blood sam-
ples were drawn after an overnight fast. All
measurements of lipid levels were performed in duplicate
in the same laboratory. LDL-cholesterol concentration
was calculated by the Friedewald formula [45]. Standard-
ized enzymatic methods were used for measuring levels
of triglycerides and HDL-cholesterol. Details of the meth-
ods have been reported elsewhere [46]. Blood pressure
was measured with a random-zero sphygmomanometer.
Average of three measurements was used in the analysis.
Blood pressure was included into analyses because it had
previously been shown to predict IMT among young
adults from 33 to 39 years [42].
Statistical analyses
The interactions between FMD and VE and between
CAC and VE in predicting carotid IMT were tested using
linear regression analyses (SPSS Version 16.0). The main
effects of age, VE, FMD and baseline brachial diameter
were included in the regression analyses when examining
the interaction between FMD and VE in predicting IMT.
The main effects of age, VE and CAC were included in
the regression model testing the interaction between
CAC and VE. Vital exhaustion and ultrasound measures
included in the interactions were centralized. The main
effects of the risk factors (serum LDL-cholesterol levels,
serum HDL-cholesterol levels, triglyceride levels, systolic
blood pressure and diastolic blood pressure) were addi-
tionally included into the FMD x VE interaction model asChumaeva et al. BMC Cardiovascular Disorders 2010, 10:34
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well as into the CAC x VE interaction model adjusted for
the cardiovascular risk factors. The three-way interac-
tions FMD x VE x sex and CAC x VE x sex were also
tested. The analyses were carried out for the whole sam-
ple and among women and men separately.
Results
The mean values for the study parameters are presented
in Table 1.
Linear regression analyses showed that FMD as well as
CAC were not related to IMTs for the women or men (p =
0.391, p = 0.626 and p = 0.595, p = 0.124, respectively). VE
was not related to IMT among the women (p = 0.744),
whereas VE was positively related to IMT among the men
(p = 0.036).
Table 2 presents the results of linear regression analyses
of age and cardiovascular risk factors on carotid IMT
among the women and men. Age was positively associ-
ated with IMT both in the women and men. HDL-choles-
terol level was associated with IMT among the women.
The flow-mediated dilatation x vital exhaustion interaction 
in relation to intima-media thickness
Table 3 presents the results of linear regression analyses
of the interactions of FMD with VE for IMT performed a)
for all participants together, b) separately for the women
and men.
The interaction of FMD and VE for IMT was found to
be non-significant for the whole sample (p = 0.984) and
when the women and men were analyzed separately (p =
0.796 and p = 0.483, respectively). The associations
remained non-significant after adjustments for tradi-
tional cardiovascular risk factors. The three-way interac-
tion analysis showed that the FMD x VE x sex interaction
was non-significant (p = 0.138) even after adjusting for
the cardiovascular risk factors (p = 0.070) (Table 4).
Table 1: Characteristics of the study participants (Total N = 1721)
Women Men
Variable Mean (SD) N Mean (SD) N p-value
Age, years (24-39) 31.58 5.03 1002 31.76 5.08 719 0.467ns
Baseline brachial diameter, (mm) 3.11 0.32 949 3.99 0.44 653 0.000***
Flow-mediated dilatation, FMD (%) 8.81 4.55 949 6.92 4.04 653 0.000***
Carotid artery compliance, CAC (%/10 mmHg) 2.31 0.77 999 2.01 0.66 716 0.000***
Carotid intima-media thickness, IMT (mm) 0.57 0.08 1002 0.59 0.10 719 0.000***
Vital exhaustion, VE 0.47 0.39 1002 0.35 0.34 719 0.000***
LDL-cholesterol (mmol/l) 3.17 0.77 997 3.44 0.91 714 0.000***
HDL-cholesterol (mmol/l) 1.40 0.31 997 1.17 0.28 714 0.000***
Triclycerids (mmol/l) 1.17 0.58 997 1.44 0.77 714 0.000***
Systolic BP (mm Hg) 117.30 13.06 601 116.36 13.18 491 0.236 ns
Diastolic BP (mm Hg) 71.29 10.66 601 70.37 10.96 491 0.161 ns
*** < .001; ns - non-significant.
HDL = high density lipoprotein, LDL = low density lipoprotein, BP = blood pressure.
P-values refer to the mean differences between the men and women.
Table 2: Regression analysis of age and cardiovascular risk 
factors on carotid IMT among the women (N = 596) and 
men (N = 486)
βt - v a l u e p - v a l u e
Women
Age 0.32 8.15 0.000***
LDL-cholesterol (mmol/l) 0.02 0.62 0.537
HDL-cholesterol (mmol/l) -0.08 -1.97 0.049*
Triclycerids (mmol/l) -0.02 -0.50 0.615
Systolic BP (mm Hg) 0.09 1.66 0.096
Diastolic BP (mm Hg) 0.04 0.70 0.485
Men
Age 0.34 7.56 0.000***
LDL-cholesterol (mmol/l) 0.07 1.67 0.095
HDL-cholesterol (mmol/l) -0.02 -0.48 0.630
Triclycerids (mmol/l) -0.07 -1.46 0.144
Systolic BP (mm Hg) 0.01 0.14 0.889
Diastolic BP (mm Hg) 0.01 0.24 0.812
*< .05, ***< .001.
HDL = high density lipoprotein, LDL = low density lipoprotein, BP = 
blood pressure.Chumaeva et al. BMC Cardiovascular Disorders 2010, 10:34
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The carotid artery compliance x vital exhaustion 
interaction in relation to intima-media thickness
Table 3 also shows the results of linear regression analy-
ses of the interactions of CAC with VE for IMT a) for all
participants together, b) separately for the women and
men. The interaction of CAC and VE for IMT was non-
significant when the analysis was carried out for the
whole sample (p = 0.250) and for the women (p = 0.651).
However, the CAC x VE interaction was significantly
related to IMT in the men (p = 0.046, N = 716). This asso-
ciation remained significant after adjustments for cardio-
vascular risk factors only among the men (p = 0.025)
(Table 3). The results of the three-way interaction analy-
sis demonstrated a significant CAC x VE x sex interaction
(p = 0.005). This interaction remained significant in a
m o d e l  a d j u s t e d  w i t h  c a r d i o v a s c u l a r  r i s k  f a c t o r s  ( p  =
0.006) (Table 4).
Linear regression analyses conducted separately for the
high (N = 281) and low (N = 435) CAC men (median
split) showed that high VE significantly related to high
IMT levels among the men with low CAC (β = 0.113, p =
0.019, N = 435), but not among the men with high CAC
(β = 0.031, p = 0.609, N = 281).
Discussion
The different roles of cardiovascular risk factors in men
and women have recently been discussed [47]. Many risk
factors, including stress-related psychosocial coronary
risk factors (e. g., social isolation, VE) have been reported
to have a greater impact on CHD progression in men
compared to women, especially in stressful psychosocial
conditions [1]. In line with these findings and with our
hypothesis, we found a significant CAC x VE interaction
for IMT only in the men. This association persisted after
all adjustments, showing that age and traditional cardio-
vascular risk factors may have an additional harmful pres-
sure in relation to atherosclerosis. The results of the
three-way interactions analyses represent that the inter-
action between CAC and VE are statistically different
between men and women. Our results imply that high VE
significantly predicted high IMTs among the men with
low CAC, but not among the women with low CAC or
among the women or men with high CAC.
In the previous studies, we found the interactions of VE
and acute stress reactivity/recovery with preclinical ath-
erosclerosis only in the men [24], and a differential effect
of VE in men compared to women [34]. In addition,
chronic stress has been shown to be associated with IMT
only in men in the recent CRYF study [48]. Furthermore,
Table 3: Regression analysis of the interaction between 
vital exhaustion and flow-mediated dilatation/carotid 
artery compliance in relation to IMT
R2*R 2 change** pN
FMD responses
FMD x VE1 0.129 0.000 0.984 1602
(all FMD responses)
#FMD x VE1 0.175 0.000 0.678 985
(all FMD responses)
FMD x VE1 (women) 0.109 0.000 0.796 949
#FMD x VE1 (women) 0.129 0.001 0.335 555
FMD x VE1 (men) 0.136 0.001 0.483 653
#FMD x VE1 (men) 0.189 0.000 0.631 430
CAC responses
CAC x VE1 0.121 0.001 0.250 1715
(all CAC responses)
#CAC x VE1 0.167 0.001 0.358 1076
(all CAC responses)
CAC x VE1 (women) 0.108 0.000 0.651 999
#CAC x VE1 (women) 0.135 0.003 0.185 593
CAC x VE1 (men) 0.124 0.005 0.046 716
#CAC x VE1 (men) 0.177 0.009 0.025 483
Note. VE = vital exhaustion, FMD = flow-mediated dilatation (%), CAC 
= carotid artery compliance (%/10 mmHg).
1 The main effects were included in each analysis, but they are not 
presented in the table.
*Calculated for the whole model.
**Refers to the interaction term.
#Additionally adjusted for cardiovascular risk factors: LDL-
cholesterol, HDL-cholesterol, triglycerides, systolic and diastolic 
blood pressure.
Table 4: The three-way interactions between sex, VE and 
FMD on carotid IMT and between sex, VE and CAC on 
carotid IMT
R2*R 2 change** pN
FMD responses
FMD x VE x sex1 0.130 0.001 0.138 1602
#FMD x VE x sex1 0.177 0.003 0.070 985
CAC responses
CAC x VE x sex1 0.113 0.004 0.005 1715
#CAC x VE x sex1 0.159 0.006 0.006 1076
Note. VE = vital exhaustion, FMD = flow-mediated dilatation (%), CAC 
= carotid artery compliance (%/10 mmHg).
1 The main effects were included in each analysis, but they are not 
presented in the table.
*Calculated for the whole model.
**Refers to the interaction term.
#Additionally adjusted for cardiovascular risk factors: LDL-
cholesterol, HDL-cholesterol, triglycerides, systolic and diastolic 
blood pressure.Chumaeva et al. BMC Cardiovascular Disorders 2010, 10:34
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compared to women, men with high levels of cardiovas-
cular risk factors have been found to demonstrate
decreased elasticity and a significantly increased risk of
structural atherosclerosis progression [41]. Taken
together, our current results imply that the effects on ath-
erosclerosis are more pronounced in high vitally
exhausted men with decreased CAC compared to women
having the same levels of VE and CAC. These findings are
in line with the concept of the female sex hormone's
(estrogen) protective role in connection with atheroscle-
rosis progression [40]. Vital exhaustion belongs to one of
the types of prolonged (chronic) stress. Chronic psycho-
logical stress has often been linked to estrogens in
women. Thus, preventive role of estrogen on depression-
like behavior has been found in the latest research when
estrogen therapy has been applied on the animal depres-
sion model [49]. On the other hand, estrogens have been
reported to decrease total cholesterol and LDL-choles-
terol levels [50,51]. A vasodilatory effect of estrogens on
the walls of vessels has been shown, and, in addition, the
atheroprotective effect via inhibition of smooth-muscle
cell proliferation [52]. Moreover, estrogens have been
found to decrease arterial stiffness [53], therefore, estro-
gens may increase arterial compliance (high arterial com-
pliance is an indicator of good arterial elasticity, whereas
high arterial stiffness indicates impaired arterial elastic-
ity). Our findings are also in accordance with the idea of
men's decreased stress coping [1], as well as with the
response-to-injury model of atherosclerosis development
[9].
The possible mechanism explaining the interactions of
VE and CAC on atherosclerosis progression could be par-
ticipation of the HPA axis [33] and the sympathetic-para-
sympathetic balance [34] in stress-related vascular
disease development, possibly by triggering endothelial
dysfunction [35], which can be related to structural alter-
ations of the arterial walls [38], increasing the sensitivity
of the vasculature to the harmful influence of risk factors
and contributing to the pathogenesis of the atheroscle-
rotic process. In addition, proinflammatory [28-31] and
procoagulant alterations [26,27] have been found to play
a role in VE and atherogenesis relations. Van der Ven and
coauthors [28] have found that VE is associated with (1)
increased levels of cytokines, (2) increased procoagulant
activity and (3) multiple herpes virus infections. In addi-
tion, elevated levels of both serum cytokines concentra-
tions and tumor necrosis factor alpha have recently been
reported to be associated with VE in patients with cardio-
vascular risk factors [54]. Increased cytokines levels have
also been reported in patients, who are exhausted after
percutaneous coronary intervention [31]. It has been
shown earlier, that cytokines may affect the brain and
evoke the sense of life discomfort and feelings of fatigue
and tiredness [55-57]. On the other hand, the relationship
between endothelial dysfunction and inflammatory pro-
cesses in the walls of vessels, which can foster atheroscle-
rosis development, have recently been reported in the
CRYF study [58]. Endothelial dysfunction has been con-
sidered to be an earlier indicator for the structural
changes of the arterial walls [38]. Reduced arterial com-
pliance reflects structural abnormalities/alterations of the
walls of vessels, which are associated with the diseases
and/or age [38]. In addition, the associations between VE
and body mass index, suggested that reducing VE levels
can play a role in reducing the prevalence of obesity have
recently been found in ARIC study [59]. On the other
hand, it has been demonstrated in the CRYF study, that
young adults (aged 24-39 years) with metabolic syndrome
have increased carotid IMTs and decreased CAC [60].
Possible links between obesity and VE [59], between met-
abolic factors and carotid atherosclerosis, which has been
shown earlier [61], as well as between the metabolic syn-
drome and CAC [60] offer another potential explanation
for the relations found between VE, CAC and carotid ath-
erosclerosis.
No significant FMD x VE interactions for IMT in the
women or men were found. These results are in agree-
m e n t  wi t h  a  r ec e n t  fi n d i n gs  t h a t  CA C  i s  m o r e  c l ose l y
related to coronary risk than FMD [62] and consistent
with the idea that in some conditions arterial compliance/
arterial stiffness may be a more sensitive and more effec-
tive risk marker than FMD [7,62], because many risk fac-
tors can influence the elastic properties of vessels
[7,12,63]. Indexes of arterial elasticity have been found to
be highly important for identification of cardiovascular
events risk and for determining the level of intervention
[7]. Thus, the predictive value of aortic stiffness on pri-
mary stroke in hypertensive patients has been shown
[64]. Future studies are needed to confirm the predictive
values of arterial stiffness on cardiovascular events. In
addition, patients at risk for cardiovascular events may
benefit from earlier recognition of impaired arterial com-
pliance and vascular abnormality. Earlier recognition and
a reduction of arterial stiffening may decrease a risk and
prevent cardiovascular events [38]. Several non-invasive
arterial elasticity tests have recently been created by vari-
ous medical-research companies and some tests, such as
measuring of arterial stiffness and arterial compliance,
are under clinical evaluation.
Vital exhaustion was shown in the present study to
exert an effect on IMT in the young men with impaired
arterial elasticity. The distinction of VE from depression
remains a subject of discussion. Exhaustion symptoms
such as sleep alterations and feelings of weakness overlap
with depressive symptomatology. It has been found in the
comparative depression/vital exhaustion study that VE
and depressive symptomatology correlated strongly
(shared a common variance of 38%: [65]). However, aChumaeva et al. BMC Cardiovascular Disorders 2010, 10:34
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"depressed" mood, the key symptom of depression, is
usually absent in exhausted individuals [66]. Many stud-
ies have distinguished VE from depression, in that
exhausted subjects have characterized by the absence of
the main symptoms for depressive disorders: feelings of
guilt, sadness, or feelings of worthlessness. Vitally
exhausted subjects are typically characterized by demor-
alization, whereas the lowered self-esteem is a symptom
of depression [19]. In the study, which assesses the differ-
ences between depression and VE in 12640 participants
from Hungary, most depressed subjects (77%: [65]) inves-
tigated have been found to be exhausted, but cognitive
and mood disturbances, the important symptoms of
depression, have been shown to be usually absent in
exhausted subjects [65]. In line with these findings and
w i t h  [ 6 6 ]  t h e  d e p r e s s i v e  s y m p t o m s  h a v e  b e e n  d e m o n -
strated to be a distinct from the concept of VE in 822 par-
ticipants studied in Augsburg Cohort Study [67]. In
addition, depressive symptoms and VE have been pre-
sented to be differentially related to behavioral risk fac-
tors for cardiovascular diseases: VE has been associated
with increased probability of cardiovascular disorders
and history of cardiovascular treatment, whereas depres-
sive symptomatology with increased risk for illegal drug
uses, alcohol abuse, congenital disorders, disabilities and
hostility [65]. Finally, depression has typically considered
to be a disease, whereas VE - a psychological state.
Methodological considerations
There are some limitations in the present study. First, we
measured carotid IMT from the left carotid artery, not
from the internal carotid artery. However, previous data
support the use of the common carotid artery IMT in
both studies of risk factor associations and cohort studies
[68,69]; the reproducibility of our measurements is com-
parable with other reports [69].
Second, we found relatively large within-subject long-
term variation in FMD [14] and CAC measurements [15],
which is in agreement with previous reports [70-72]; the
long-term reproducibility of the carotid and brachial
diameter measurements was very good, which suggests
that much of the variation in CAC and FMD is due to
physiological fluctuation. However, the large variability of
FMD and CAC is a limitation.
The present analysis was conducted in participants
aged 24 to 39. Our results cannot be generalized to older
individuals with more definite atherosclerosis. Also,
owing to the cross-sectional nature of the present study,
it is impossible to make statements regarding atheroscle-
rosis progress. We conducted several analyses, but not as
many significant associations were found as was
expected. Therefore, the possibility of a chance finding
cannot be excluded. The CAC and VE interaction
explains 0.5% of the variance in IMT in the men. This is a
small amount, and we need to mention this point as an
additional limitation of the study. Taking these limits into
consideration, our results need to be viewed cautiously
and replicated in future research.
The strength of our study is a comparatively large pop-
ulation-based sample. Furthermore, we were able to
examine both men and women, which is important as it
has been repeatedly shown that results related to cardio-
vascular diseases cannot be generalized from men to
women or vice versa. Our study focused on young adults
and brought important information on atherosclerosis
development in a stage when clinical symptoms of carotid
artery disease are rarely seen.
Conclusions
We can conclude that unlike women, young asymptom-
atic men having high VE in combination with reduced
arterial elasticity are at increased risk of atherosclerotic
progression in early life. This is in line with the findings
reporting that many cardiovascular risk factors have a
greater impact on CHD in men than in women, and in
line with the concept of men's decreased stress coping in
relation to stressful psychological conditions.
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